German Pharma Wants Inflation-Linked Deal To Replace Drug Price Freeze
This article was originally published in The Pink Sheet Daily
Executive Summary
With the German drug price freeze set to continue, the pharmaceutical industry wants to see at least an inflation-linked rise in prices and the abandonment of HTA for older products.